PHYSIOLOGICALLY-BASED PHARMACOKINETIC ANALYSES OF SIMPLE MIXTURES

被引:33
|
作者
KRISHNAN, K
CLEWELL, HJ
ANDERSEN, ME
机构
[1] UNIV MONTREAL,FAC MED,DEPT MED TRAVAIL & HYG MILIEU,MONTREAL,PQ,CANADA
[2] CHEM IND INST TOXICOL,RES TRIANGLE PK,NC
[3] MANTECH ENVIRONM TECHNOL INC,DAYTON,OH
关键词
PHYSIOLOGICAL PHARMACOKINETICS; PBPK MODELING; CHEMICAL MIXTURES; TOXICOKINETIC INTERACTION;
D O I
10.1289/ehp.94102s9151
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Exposure to multiple chemicals may cause significant alterations of tissue dose of the toxic moiety of one or more of the individual chemicals. The change in target tissue dose of a chemical present in simple mixtures can be predicted when the determinants of disposition of each chemical, and the mechanism of toxicokinetic interaction between chemicals are understood at a quantitative level. Determinants of disposition include physiological (e.g., breathing rates, cardiac output, tissue volumes, blood flow rates), biochemical (e.g., kinetic constants for metabolism and protein binding), and physicochemical factors (e.g., blood:air and tissue:blood partition coefficients). Mechanisms of toxicokinetic interactions refer to the manner in which coexposure alters these determinants of disposition as compared to exposure to the individual chemicals. Interactions between chemicals can be described quantitatively with physiologically based pharmacokinetic (PBPK) models, which integrate these mechanistic determinants and permit prediction of alterations in tissue dose for various exposure situations by computer simulation. PBPK modeling studies of binary chemical interactions conducted so far indicate that inhibitory rather than potentiating metabolic interactions are more likely to be observed during multiple chemical exposures. As PBPK models of representative binary, tertiary and quaternary mixtures are developed, it will become increasingly possible to draw reliable conclusions about the risk associated with human exposure to chemical mixtures.
引用
收藏
页码:151 / 155
页数:5
相关论文
共 50 条
  • [21] The development of a stochastic physiologically-based pharmacokinetic model for lead
    Beck, BD
    Mattuck, RL
    Bowers, TS
    Cohen, JT
    O'Flaherty, E
    SCIENCE OF THE TOTAL ENVIRONMENT, 2001, 274 (1-3) : 15 - 19
  • [22] A physiologically-based pharmacokinetic model of drug detoxification by nanoparticles
    Fallon, MS
    Varshney, M
    Dennis, DM
    Chauhan, A
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2004, 31 (05) : 381 - 400
  • [23] Physiologically-based pharmacokinetic modeling of ziprasidone in pregnant women
    Biesdorf, Carla
    Martins, Frederico
    Diniz, Andrea
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2018, 45 : S12 - S13
  • [24] A Comprehensive Framework for Physiologically-Based Pharmacokinetic Modeling in Matlab
    Stader, Felix
    Penny, Melissa A.
    Siccardi, Marco
    Marzolini, Catia
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2019, 8 (07): : 444 - 459
  • [25] Physiologically-Based Pharmacokinetic Modeling: Parameter Estimation for Cyclosporin A
    Lueshen, Eric
    Hall, Cierra
    Mosat, Andrej
    Linninger, Andreas
    21ST EUROPEAN SYMPOSIUM ON COMPUTER AIDED PROCESS ENGINEERING, 2011, 29 : 1543 - 1547
  • [26] Physiologically-based pharmacokinetic modelling in veterinary medicine.
    Chapel, AM
    Sanders, P
    REVUE DE MEDECINE VETERINAIRE, 1996, 147 (05) : 359 - 366
  • [27] An Overview of Physiologically-Based Pharmacokinetic Models for Forensic Science
    Fairman, Kiara
    Choi, Me-Kyoung
    Gonnabathula, Pavani
    Lumen, Annie
    Worth, Andrew
    Paini, Alicia
    Li, Miao
    TOXICS, 2023, 11 (02)
  • [28] A Physiologically-Based Pharmacokinetic Model of Drug Detoxification by Nanoparticles
    Marissa S. Fallon
    Manoj Varshney
    Donn M. Dennis
    Anuj Chauhan
    Journal of Pharmacokinetics and Pharmacodynamics, 2004, 31 : 381 - 400
  • [29] PREDICTION OF ANTICHOLINESTERASE ACTIVITY AND URINARY METABOLITES OF ISOFENPHOS - USE OF A PERCUTANEOUS PHYSIOLOGICALLY-BASED PHARMACOKINETIC PHYSIOLOGICALLY-BASED PHARMACODYNAMIC MODEL
    KNAAK, JB
    ALBAYATI, MA
    RAABE, OG
    BLANCATO, JN
    BIOMARKERS OF HUMAN EXPOSURE TO PESTICIDES, 1994, 542 : 284 - 300
  • [30] Physiologically-based pharmacokinetic model of topical intravaginal HIV prevention
    Kay, Katherine
    Rohan, Lisa C.
    Shah, Dhavalkumar
    Bies, Robert
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2017, 44 : S88 - S88